Literature DB >> 11589595

Which is less invasive--distal pancreatectomy or segmental resection?

K Yamaguchi1, K Yokohata, M Ohkido, M Watanabe, Y Ogawa, K Chijiiwa, M Tanaka.   

Abstract

BACKGROUND: For a pancreatic body tumor, distal pancreatectomy (DP) has been a standard operation. Segmental resection (SR) of the pancreas has been introduced as a less invasive procedure in consideration of preservation of the pancreatic functions and postoperative quality of life. Surgical stress and exocrine and endocrine functions of the residual pancreas were compared between DP and SR.
METHODS: Clinical findings including serum levels of C reactive protein (CRP), fasting blood sugar, a 120 min value of the 75 g oral glucose tolerance test, and N-benzol-L-tyrosyl-p-aminobenzoic acid excretion value (a pancreatic exocrine function test) were compared between 47 patients with DP and 10 with SR performed for benign pancreatic diseases.
RESULTS: Operation time was longer in SR (356 min) than in DP (272 min; P = 0.0123). Operative blood loss and peri-operative blood transfusion were not different between the two groups. Serum levels of CRP increased after the operation, reaching the peak on postoperative day 2 or 3, and decreased thereafter The peak of serum CRP level was similar between the two groups (13.4+/-1.8 mg/dl in SR and 14.8+/-1.1 mg/dl in DP). Postoperative hospital stay in 10 patients with SR (65 days) was significantly longer than that in 47 with DP (33 days; P = 0.0001). When postoperative complications were compared between the two groups, the incidence of pancreatic fistula was significantly higher in SR (4/10 [40%]) than in DP (4/46 [9%]; P = 0.0103). Abdominal abscess was seen in 30% of SR and in 11% of DP. Postoperative intra-abdominal hemorrhage was seen only in one patient with SR After DP, glucose tolerance deteriorated at short-term in nine of 24 patients examined and at long-term in two of five patients examined. Only one patient showed improvement of glucose intolerance at short-term after the operation. On the other hand, SR showed no alteration of the pancreatic endocrine and exocrine functions in eight patients examined.
CONCLUSIONS: SR is superior to DP from the view-point of preservation of the pancreatic functions, although SR has a longer operation time, a longer hospital stay and a higher incidence of postoperative complications.

Entities:  

Mesh:

Year:  2000        PMID: 11589595

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  10 in total

Review 1.  Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Rebecca M Minter; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2011-10-19       Impact factor: 3.452

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  Middle segmental pancreatic resection: An option to treat benign pancreatic body lesions.

Authors:  Michael W Müller; Helmut Friess; Jörg Kleeff; Ulf Hinz; Moritz N Wente; Daniel Paramythiotis; Pascal O Berberat; Güralp O Ceyhan; Markus W Büchler
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

Review 4.  Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.

Authors:  Henning Dralle; Sabine L Krohn; Wolfram Karges; Bernhard O Boehm; Michael Brauckhoff; Oliver Gimm
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

5.  Combined laparoscopic spleen-preserving distal pancreatectomy and islet autotransplantation for benign pancreatic neoplasm.

Authors:  Gianpaolo Balzano; Michele Carvello; Lorenzo Piemonti; Rita Nano; Riccardo Ariotti; Alessia Mercalli; Raffaella Melzi; Paola Maffi; Marco Braga; Carlo Staudacher
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  Middle pancreatectomy: indications, short- and long-term operative outcomes.

Authors:  Stefano Crippa; Claudio Bassi; Andrew L Warshaw; Massimo Falconi; Stefano Partelli; Sarah P Thayer; Paolo Pederzoli; Carlos Fernández-del Castillo
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

Review 7.  [Middle segmental pancreatic resection: an organ-preserving option for benign lesions].

Authors:  M W Müller; V Assfalg; C W Michalski; P Büchler; J Kleeff; H Friess
Journal:  Chirurg       Date:  2009-01       Impact factor: 0.955

8.  Clinical efficacy of organ-preserving pancreatectomy for benign or low-grade malignant potential lesion.

Authors:  Seung Eun Lee; Jin-Young Jang; Dae Wook Hwang; Kuhn Uk Lee; Sun-Whe Kim
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

9.  The Dagradi-Serio-Iacono operation central pancreatectomy.

Authors:  Calogero Iacono; Luca Bortolasi; Enrico Facci; Filippo Nifosì; Silvia Pachera; Andrea Ruzzenente; Alfredo Guglielmi
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

10.  Overall Postoperative Morbidity and Pancreatic Fistula Are Relatively Higher after Central Pancreatectomy than Distal Pancreatic Resection: A Systematic Review and Meta-Analysis.

Authors:  Parbatraj Regmi; Qing Yang; Hai-Jie Hu; Fei Liu; Hare Ram Karn; Wen-Jie Ma; Cong-Dun Ran; Fu-Yu Li
Journal:  Biomed Res Int       Date:  2020-02-22       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.